Business expansion
Est; Alsace; Bas-Rhin
Location of affected unit(s)
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72.11 - Research and experimental development on biotechnology

100 jobs
Number of planned job creations
Job creation
Announcement Date
19 June 2020
Employment effect (start)
1 July 2020
Foreseen end date
30 June 2023


Polyplus Transfection, a company specialised in the transfer of genetic material into human cells, has invested in a new production site and plans to recruit 100 employees within three years. This investment of €30 million in three years will enable it to expand from a site of a few hundred to 4,000 sqm. The aim is to keep pace with the growth in turnover, which has increased by 70% a year over the last five years. The work, started in the spring of 2020, will allow a first move in the summer of 2021 and will be completed in 2023 with the delivery of a new factory. This investment will increase Polyplus' production capacity tenfold. 



Eurofound (2020), Polyplus Transfection, Business expansion in France, factsheet number 100952, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/100952.